Tel Aviv, Israel

Yael Bresler

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Yael Bresler

Introduction

Yael Bresler is a notable inventor based in Tel Aviv, Israel. He has made significant strides in the field of medical research, particularly in enhancing the permeability of the blood-brain barrier. His work is crucial for developing new treatments for various neurological conditions.

Latest Patents

Yael Bresler holds a patent for a method aimed at changing blood-brain barrier permeability. This innovative system involves the controlled application of pulsed electric fields to increase the permeability of barriers such as the blood-brain barrier or the blood-cerebrospinal fluid barrier. This patent represents a significant advancement in medical technology, with the potential to improve drug delivery to the brain.

Career Highlights

Bresler is associated with Tel Hashomer Medical Research Infrastructure and Services Ltd., where he contributes to groundbreaking research. His work focuses on developing methods that can lead to better treatment options for patients with neurological disorders.

Collaborations

Yael Bresler collaborates with esteemed colleagues, including Yael Mardor and Shirley Sharabi. Their combined expertise enhances the research efforts at their institution, fostering an environment of innovation and discovery.

Conclusion

Yael Bresler's contributions to medical research and his innovative patent highlight his role as a leading inventor in the field. His work has the potential to transform treatment methodologies for neurological conditions, paving the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…